发明名称 Bi- and monospecific, asymmetric antibodies and methods of generating the same
摘要 An antibody is provided. The antibody comprises an Fc region and a Fab region, wherein: (i) the Fc region comprises two non-identical heavy chains, wherein at least one of the two non-identical heavy chains comprises an amino acid modification so as to form complementation between the two non-identical heavy chains thereby increasing the probability of forming heterodimers of the non-identical heavy chains and decreasing the probability of forming homodimers of identical heavy chains; and(ii) the Fab region comprises a first covalent link between a first heavy chain and a first light chain of the Fab region and a second covalent link between a second heavy chain and a second light chain of said Fab region, wherein a position of the first covalent link relative to the first heavy chain is different to a position of the second covalent link relative to the second heavy chain.
申请公布号 US9624291(B2) 申请公布日期 2017.04.18
申请号 US201214005580 申请日期 2012.03.15
申请人 Ramot at Tel-Aviv University Ltd. 发明人 Benhar Itai;Vaks Lilach
分类号 C07K16/00;C07K16/32;C07K16/28;A61K39/00 主分类号 C07K16/00
代理机构 代理人
主权项 1. A method of preparing a bispecific antibody comprising an Fc region and a Fab region, (a) providing a first nucleic acid molecule encoding a first heavy chain having a tryptophan at position 366 on a CH3 domain so as to generate a protuberance; (b) providing a second nucleic acid molecule encoding a second heavy chain having a serine at position 366, an anlanine at position 368 and a valine at position 407 on a CH3 thereof wherein the VH domain of said second heavy chain further comprises a cysteine at position 44 and an alanine at position 222; (c) providing a third nucleic acid molecule encoding a native first light chain; (d) providing a fourth nucleic acid molecule encoding a second light chain, wherein the VL domain thereof has a cysteine at position 100 and has a cysteine deletion at the position of its native disulfide bond with said second heavy chain; (e) culturing host cells comprising said first, second, third and fourth nucleic acid molecules under conditions that permit expression of the nucleic acid molecules; and (f) recovering the antibody, wherein the numbering of said position is according to Kabat and Wu.
地址 Tel-Aviv IL